Entera Bio
ENTX
19 hedge funds and large institutions have $19.4M invested in Entera Bio in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
12% more capital invested
Capital invested by funds: $17.4M → $19.4M (+$2.02M)
6% more funds holding
Funds holding: 18 → 19 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.02% less ownership
Funds ownership: 24.49% → 22.47% (-2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bessemer Group
Woodbridge,
New Jersey
|
+$278K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$97.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$30.9K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$27.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$248K |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$166K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$21.3K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$18.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$14.9K |
ENTX Hedge Fund Activity: Q2 2025 in Review
19 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q2 2025, worth a combined $19.4M — up 12% from $17.4M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ENTX positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Bessemer Group, opening a new position worth an estimated $278K. The largest seller was Perigon Wealth Management, exiting entirely with an estimated $248K sold.
- 19 institutional investors held Entera Bio (ENTX) as of Q2 2025, up from 18 in Q1 2025.
- Funds reported $19.4M of Entera Bio stock for Q2 2025, up 12% quarter-over-quarter.
- 4 funds opened new Entera Bio positions in Q2 2025 and 3 closed out, a net change of +1 holder.
- The largest Entera Bio buyer in Q2 2025 was Bessemer Group, an estimated $278K added.
- The largest Entera Bio seller in Q2 2025 was Perigon Wealth Management, an estimated $248K sold.
Based on aggregated 13F filings for Q2 2025.